Skip to main content
Log in

Therapie chronischer Schmerzen

Chronic pain management

  • Arzneimitteltherapie
  • Published:
Der Internist Aims and scope Submit manuscript

Zusammenfassung

Schmerz ist eine der häufigsten Beschwerden, die den Patienten zum Arzt führen. Daher ist die Kenntnis häufiger Schmerzdiagnosen und möglicher Therapieansätze essenziell. Zahlreiche medikamentöse und interventionelle Therapieoptionen stehen in Klinik und Praxis zur Verfügung, um Schmerzerkrankungen kausal und symptomatisch zu behandeln. Chronische neuropathische Schmerzen können wirksam durch Medikamente gelindert werden. Auch interventionelle Verfahren können effektiv in der Schmerztherapie eingesetzt werden, wie die Spinal Cord Stimulation bei therapierefraktärer Angina pectoris. Bei bestimmten Krankheitsbildern (Phantomschmerz, M. Sudeck) sind ergotherapeutische Verfahren (z. B. Spiegeltherapie) sinnvoll. Die konsequente Diagnose und Therapie akuter Schmerzen ist die beste Prophylaxe chronischer Schmerzen.

Abstract

Pain is one of the major complaints leading to doctor visits. Therefore basic knowledge of frequent pain diagnoses and possible treatment approaches is essential. Numerous medical and interventional therapeutic options are available for causal or symptomatic treatment of pain. The treatment of neuropathic pain is often difficult and demands special knowledge. Antidepressants like amitriptyline and anticonvulsive drugs are the first choice in these cases. Also interventional approaches are useful, such as spinal cord stimulation for angina pectoris. For the treatment of complex regional pain syndrome and phantom pain the use of mirror feed-back is a new effective method for pain relief. The only way to prevent from development of chronic pain is the early and effective treatment of acute pain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1

Literatur

  1. Ahmedzai S, Brooks D (1997) Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. J Pain Symptom Manage 13: 254–261

    Article  PubMed  CAS  Google Scholar 

  2. Arnold B, Brinkschmidt T, Casser HR et al. (2009) Multimodale Schmerztherapie: Prinzipien und Indikationen. Schmerz 23: 112–120

    Article  PubMed  CAS  Google Scholar 

  3. Bickel A (2009) Neuropathische Schmerzen – Hilfe für die Therapieauswahl. MMW Fortschr Med 17: 40–44

    Google Scholar 

  4. Börjesson M, Andrell P, Lundberg D, Mannheimer C (2008) Spinal cord stimulation in severe angina pectoris – a systematic review based on the Swedish Council on Technology assessment in health care report on long-standing pain. Pain 140: 501–508

    Article  PubMed  Google Scholar 

  5. Christo PJ, Mazloomdoost D (2008) Cancer pain and analgesia. Ann N Y Acad Sci 1138: 278–298

    Article  PubMed  CAS  Google Scholar 

  6. Christrup LL, Foster D, Popper LD et al. (2008) Pharmacokinetics, efficacy, and tolerability of fentanyl following intranasal versus intravenous administration in adults undergoing third-molar extraction: a randomized, double-blind, double-dummy, two-way, crossover study. Clin Ther 30: 469–481

    Article  PubMed  CAS  Google Scholar 

  7. Clemens KE, Klaschik E (2008) Management of constipation in palliative care patients. Curr Opin Support Palliat Care 2: 22–27

    Article  PubMed  Google Scholar 

  8. Coluzzi PH, Schwartzberg L, Conroy JD et al. (2001) Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate and morphine sulfate immediate release. Pain 91: 123–130

    Article  PubMed  CAS  Google Scholar 

  9. Deutscher Bundestag (2003) Antwort des Bundestages auf die Anfrage von Dr. D. Thomae, Detlef Parr und Dr. H.L. Kolb. Drucksache 15/2295 vom 22.12.2003

  10. Eddicks S, Maier-Hauff K, Schenk M et al. (2007) Thoracic spinal cord stimulation improves functional status and relieves symptoms in patients with refractory angina perctoris: the first placebo-controlled randomised study. Heart 93: 585–590

    Article  PubMed  Google Scholar 

  11. Falowski S, Celli A, Sharan A (2008) Spinal cord stimulation: an update. Neurotherapy 5: 86–99

    Article  Google Scholar 

  12. Frank B, Serpell MG, Hughes J et al. (2008) Comparison of analgesic effects and Patient tolerabilty of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study. BMJ 336: 199–201

    Article  PubMed  CAS  Google Scholar 

  13. Fricke E, Eckert S, Dongas A et al. (2009) Myocardial perfusion after one year of spinal cord stimulation in patients with refractory angina. Nuklearmedizin 48: 104–109

    PubMed  Google Scholar 

  14. Grötz KA, Diel IJ (2005) Osteonekrose des Kiefers unter Bisphosphonat-Langzeittherapie. Focus Onkologie 3: 52–55

    Google Scholar 

  15. Grond S, Zech D, Diefenbach C et al. (1996) Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service. Pain 64: 107–114

    Article  PubMed  CAS  Google Scholar 

  16. Hans G, Sabatowski R, Binder A et al. (2009) Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study. Curr Med Res Opin 25: 1295–1305

    Article  PubMed  CAS  Google Scholar 

  17. Harati Y, Gooch C, Swenson M et al. (1998) Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 50: 1842–1846

    PubMed  CAS  Google Scholar 

  18. Laverty D (2007) Treating cancer-related breakthrough pain: the oral transmucosal route. Int J Palliat Nurs 13: 326–331

    PubMed  Google Scholar 

  19. Levick S, Jacobs C, Loukas DF et al. (1988) Naproxen sodium in treatment of bone pain due to metastatic cancer. Pain 35: 253–258

    Article  PubMed  CAS  Google Scholar 

  20. Löwenstein O, Leyendecker P, Hopp M et al. (2009) Combined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised controlled trial. Expert Opin Pharmacother 10: 531–543

    Article  PubMed  Google Scholar 

  21. Moore RA, Moore OA, Derry S et al. (2009) Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trial: bridging a gap between clinical trials and clinical practice. Ann Rheum Dis [Epub ahead of print]

  22. Müller-Schwefe GH, Uberall MA (2008) Analgetischer und muskelrelaxierender Effekt von Flupirtin beim chronischen Rückenschmerz. MMW Fortschr Med 148: 153–161

    Google Scholar 

  23. Mystakidou K, Katsouda E, Parpa E et al. (2005) Oral transmucosal fentanyl citrate for the treatment of breabthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics. J Opioid Manag 1: 36–40

    PubMed  Google Scholar 

  24. Pfingsten M, Schöps P, Wille T, Terp L (2000) Chronifizierungsausmaß von Schmerzerkrankungen. Schmerz 14: 10–17

    Article  PubMed  CAS  Google Scholar 

  25. Portenoy R, Hagen NA (1990) Breakthrough pain; definition, prevalence, and characteristics. Pain 41: 273–281

    Article  PubMed  CAS  Google Scholar 

  26. Ramachandran VS (2005) Plasticity and functional recovery in neurology. Clin Med 5: 368–373

    PubMed  CAS  Google Scholar 

  27. Reeves RR, Burke RS (2008) Tramadol: basic pharmacology and emerging concepts. Drugs Today 44: 827–836

    Article  PubMed  CAS  Google Scholar 

  28. Reimer K, Hopp M, Zenz M et al. (2009) Meeting the challenges of opioid-induced constipation in chronic pain management – a novel approach. Pharmacology 83: 10–17

    Article  PubMed  CAS  Google Scholar 

  29. Saarto T, Wiffen PJ (2007) Antidepressants for neuropathic pain. Cochrane Database Syst Rev 17: CDOO5454

    Google Scholar 

  30. Schnitzer TJ, Burmester GR, Mysler E et al. (2004) Comparison of Lumeracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gatrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial. Lancet 364: 665–674

    Article  PubMed  CAS  Google Scholar 

  31. Schwarzer A, Glaudo S, Zenz M, Maier C (2007) Spiegeltherapie – eine neues Verfahren in der Therapie neuropathischer Schmerzen. Dtsch Med Wochenschr 132: 2159–2162

    Article  PubMed  CAS  Google Scholar 

  32. Watson CP, Babul N (1998) Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 50: 1837–1841

    PubMed  CAS  Google Scholar 

  33. Willweber-Strumpf A, Zenz M, Bartz D (2000) Epidemiologie chronischer Schmerzen: Eine Untersuchung in 5 medizinischen Praxen. Schmerz 14: 84–91

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Die korrespondierenden Autoren bestätigen, dass Verbindungen mit den Firmen Grünenthal GmbH, Mundipharma GmbH und Janssen-Cilag GmbH, deren Produkte in dem Artikel genannt werden, bestehen.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to D. Rothstein or M. Zenz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rothstein, D., Zenz, M. Therapie chronischer Schmerzen. Internist 50, 1161–1168 (2009). https://doi.org/10.1007/s00108-009-2474-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-009-2474-z

Schlüsselwörter

Keywords

Navigation